|
|
40
|
|
|
A681HE
|
|
|
ABACAVIR | LAMIVUDINE 600MG | 300MG TAB (MAT/AHI)
|
|
|
ABACAVIR|LAMIVUDINE
|
|
|
ABACAVIR|LAMIVUDINE
|
|
|
30'S
|
|
|
BL
|
|
|
63.61
|
|
|
2.12
|
|
|
600MG|300MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
MAT
|
|
|
MYLAN LABORATORIES
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
08180892
|
|
|
ANTIRETROVIRALS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|